DE3686979D1 - Cephemverbindungen und verfahren zu ihrer herstellung. - Google Patents

Cephemverbindungen und verfahren zu ihrer herstellung.

Info

Publication number
DE3686979D1
DE3686979D1 DE8686101938T DE3686979T DE3686979D1 DE 3686979 D1 DE3686979 D1 DE 3686979D1 DE 8686101938 T DE8686101938 T DE 8686101938T DE 3686979 T DE3686979 T DE 3686979T DE 3686979 D1 DE3686979 D1 DE 3686979D1
Authority
DE
Germany
Prior art keywords
heterocyclic group
halogen
hydrogen
cephem
connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686101938T
Other languages
English (en)
Other versions
DE3686979T2 (de
Inventor
Takao Takaya
Zenzaburo Tozuka
Nobuyoshi Yasuda
Shintaro Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3686979D1 publication Critical patent/DE3686979D1/de
Publication of DE3686979T2 publication Critical patent/DE3686979T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8686101938T 1985-02-18 1986-02-15 Cephemverbindungen und verfahren zu ihrer herstellung. Expired - Fee Related DE3686979T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858504072A GB8504072D0 (en) 1985-02-18 1985-02-18 Cephem compounds

Publications (2)

Publication Number Publication Date
DE3686979D1 true DE3686979D1 (de) 1992-11-26
DE3686979T2 DE3686979T2 (de) 1993-03-11

Family

ID=10574636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686101938T Expired - Fee Related DE3686979T2 (de) 1985-02-18 1986-02-15 Cephemverbindungen und verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (2) US4861769A (de)
EP (1) EP0192210B1 (de)
JP (1) JPS61246189A (de)
AT (1) ATE81655T1 (de)
DE (1) DE3686979T2 (de)
GB (1) GB8504072D0 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830051B2 (ja) * 1986-05-21 1996-03-27 武田薬品工業株式会社 4−ハロゲノ−2−置換オキシイミノ−3−オキソ酪酸のエステルまたはアミドの製造法
DE4030706A1 (de) * 1990-09-28 1992-04-02 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE4037841A1 (de) * 1990-11-28 1992-06-04 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69331576T2 (de) * 1992-09-18 2002-10-17 Otsuka Kagaku Kk Cephem-verbindungen, verfarhren zu ihrer herstellung und diese enthaltende medikamente
DE69521378T2 (de) * 1994-03-17 2002-05-29 Taiho Pharmaceutical Co Ltd Cephemderivat, verfahren zu dessen herstellung und dieses enthaltendes antibakterielles mittel
US5949237A (en) * 1996-02-03 1999-09-07 Forschungszentrum Karlsruhe Gmbh Microwave cavity resonator for continuous spectroscopic gas analysis
EP3616695A1 (de) 2011-09-09 2020-03-04 Merck Sharp & Dohme Corp. Verfahren zur behandlung von intrapulmonalen infektionen
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
CN110279698B (zh) 2013-03-15 2022-10-28 默沙东有限责任公司 头孢特咯瓒抗生素组合物
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602725A (en) * 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4468515A (en) * 1978-12-29 1984-08-28 Fujisawa Pharmaceutical Co., Ltd. 2-Substituted oxyimino-2-(5-amino-1,2,4-thiadiazol-3-yl)acetic acids
US4431642A (en) * 1980-12-01 1984-02-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
SU1195908A3 (ru) * 1982-05-31 1985-11-30 Баниу Фармасьютикал Ко.,Лтд.(Фирма) Способ получени производных 2-оксо-1-азетидинсульфокислоты или их солей с щелочными металлами
NL8302309A (nl) * 1982-06-30 1984-01-16 Glaxo Group Ltd Cefalosporinen, preparaten die ze bevatten, en werkwijzen voor de bereiding daarvan.
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen

Also Published As

Publication number Publication date
GB8504072D0 (en) 1985-03-20
DE3686979T2 (de) 1993-03-11
US4973699A (en) 1990-11-27
US4861769A (en) 1989-08-29
EP0192210A3 (en) 1988-03-30
JPS61246189A (ja) 1986-11-01
ATE81655T1 (de) 1992-11-15
EP0192210A2 (de) 1986-08-27
EP0192210B1 (de) 1992-10-21

Similar Documents

Publication Publication Date Title
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
ATE127801T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung.
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
ATE185807T1 (de) Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten
FI863917A (fi) Menetelmä valmistaa farmakologisesti käyttökelpoisia kinatsoliinijohdannaisia
HUP0203425A2 (en) Quinazoline derivatives, process for their preparation and their use
BG103417A (en) Condensed pyrimidine bicyclic derivatives
DE69021755T2 (de) Benzopyranderivate und Verfahren zu ihrer Herstellung.
ATE172731T1 (de) Pyrazolopyridinverbindung und verfahren zu ihrer herstellung
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
IL74031A0 (en) Cyanoguanidinophenyldihydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them
DE3686979T2 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE69330601D1 (de) Serotoninergische ergolin derivate
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
IL81337A (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung
FR2781482B1 (fr) Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT79486B (fr) Procede de preparation de nouveaux derives de thieno<2,3-b>pyrrole et de compositions pharmaceutiques les contenant
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee